Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05144997
Title Lorlatinib Continuation Study
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements Yes
Sponsors Pfizer
Indications

lung non-small cell carcinoma

Therapies

Lorlatinib

Age Groups: senior | adult
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
Gustave Roussy Not yet recruiting Villejuif Cedex 94805 France Details
Aichi Cancer Center Hospital Recruiting Nagoya Aichi 464-8681 Japan Details
Hospital Universitari Vall d'Hebron Recruiting Barcelona 08035 Spain Details
National Taiwan University Hospital Recruiting Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field